title: Expression of p21Waf1/Cip1 and cyclin D1 is increased in butyrate-resistant HeLa cells.
abstract: Sodium butyrate induced cell cycle arrest in mammalian cells through an increase in p21Waf1/Cip1, although another study showed that this arrest is related to pRB signaling. We isolated variants of HeLa cells adapted to growth in 5 mm butyrate. One of these variants, clone 5.1, constitutively expressed elevated levels of p21Waf1/Cip1 when incubated in regular growth medium and in the presence of butyrate. Despite this elevated level of p21Waf1/Cip1, the cells continue to proliferate, albeit at a slower rate than parental HeLa cells. Western blot analyses showed that other cell cycle regulatory proteins were not up-regulated to compensate for the elevated expression of p21Waf1/Cip1. However, cyclin D1 was down-regulated by butyrate in HeLa cells but not in clone 5.1. We conclude that continued expression of cyclin D1 allowed clone 5.1 to grow in the presence of butyrate and elevated levels of p21Waf1/Cip1.
authors.affiliation: Lady Davis Institute, Jewish General Hospital, McGill University, Montreal, Quebec, H3T 1E2, Canada.
authors.forename: A
authors.initials: A
authors.lastname: Derjuga
authors.forename: C
authors.initials: C
authors.lastname: Richard
authors.forename: M
authors.initials: M
authors.lastname: Crosato
authors.forename: P S
authors.initials: PS
authors.lastname: Wright
authors.forename: L
authors.initials: L
authors.lastname: Chalifour
authors.forename: J
authors.initials: J
authors.lastname: Valdez
authors.forename: A
authors.initials: A
authors.lastname: Barraso
authors.forename: H A
authors.initials: HA
authors.lastname: Crissman
authors.forename: W
authors.initials: W
authors.lastname: Nishioka
authors.forename: E M
authors.initials: EM
authors.lastname: Bradbury
authors.forename: J P
authors.initials: JP
authors.lastname: Th'ng
mesh_terms: D015153:Blotting, Western; D002087:Butyrates / Q000494:pharmacology*; D042846:CDC2-CDC28 Kinases; D018797:Cell Cycle Proteins / Q000378:metabolism; D002455:Cell Division; D002999:Clone Cells; D019938:Cyclin D1 / Q000235:genetics / Q000378:metabolism*; D051357:Cyclin-Dependent Kinase 2; D050759:Cyclin-Dependent Kinase Inhibitor p21; D018844:Cyclin-Dependent Kinases / Q000378:metabolism; D016213:Cyclins / Q000235:genetics / Q000378:metabolism*; D019008:Drug Resistance, Neoplasm; D006367:HeLa Cells; D006801:Humans; D011233:Precipitin Tests; D011494:Protein Kinases / Q000378:metabolism; D017346:Protein Serine-Threonine Kinases / Q000378:metabolism; D015854:Up-Regulation
chemical_list: D002087:Butyrates; C493956:CDKN1A protein, human; D018797:Cell Cycle Proteins; D050759:Cyclin-Dependent Kinase Inhibitor p21; D016213:Cyclins; D019938:Cyclin D1; D011494:Protein Kinases; C102333:histone H1 kinase; D017346:Protein Serine-Threonine Kinases; D042846:CDC2-CDC28 Kinases; C495894:CDK2 protein, human; D051357:Cyclin-Dependent Kinase 2; D018844:Cyclin-Dependent Kinases